Everpar Advisors LLC Grows Stock Position in Chemed Co. (NYSE:CHE)

Everpar Advisors LLC raised its holdings in Chemed Co. (NYSE:CHE) by 4.9% in the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 580 shares of the company’s stock after buying an additional 27 shares during the quarter. Everpar Advisors LLC’s holdings in Chemed were worth $315,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the company. Wealth Alliance increased its holdings in shares of Chemed by 3.0% in the fourth quarter. Wealth Alliance now owns 578 shares of the company’s stock valued at $338,000 after purchasing an additional 17 shares during the period. EntryPoint Capital LLC increased its holdings in shares of Chemed by 14.0% in the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after purchasing an additional 18 shares during the period. Signaturefd LLC increased its holdings in shares of Chemed by 5.8% in the fourth quarter. Signaturefd LLC now owns 385 shares of the company’s stock valued at $225,000 after purchasing an additional 21 shares during the period. Covestor Ltd increased its holdings in shares of Chemed by 10.6% in the first quarter. Covestor Ltd now owns 219 shares of the company’s stock valued at $141,000 after purchasing an additional 21 shares during the period. Finally, Ballentine Partners LLC increased its holdings in shares of Chemed by 3.4% in the first quarter. Ballentine Partners LLC now owns 660 shares of the company’s stock valued at $424,000 after purchasing an additional 22 shares during the period. 95.85% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a report on Saturday, May 4th. Royal Bank of Canada dropped their target price on Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a report on Tuesday, May 21st.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 1,500 shares of the stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $544.17, for a total transaction of $816,255.00. Following the transaction, the chief executive officer now owns 107,049 shares in the company, valued at $58,252,854.33. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $569.63, for a total value of $1,139,260.00. Following the transaction, the chief executive officer now owns 105,735 shares in the company, valued at $60,229,828.05. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Kevin J. Mcnamara sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $544.17, for a total value of $816,255.00. Following the completion of the transaction, the chief executive officer now owns 107,049 shares in the company, valued at approximately $58,252,854.33. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 5,784 shares of company stock worth $3,232,313. 3.32% of the stock is owned by corporate insiders.

Chemed Stock Performance

Chemed stock traded up $3.28 during midday trading on Friday, hitting $576.28. 39,762 shares of the company were exchanged, compared to its average volume of 88,017. The firm has a market capitalization of $8.72 billion, a PE ratio of 31.02, a price-to-earnings-growth ratio of 2.40 and a beta of 0.43. Chemed Co. has a fifty-two week low of $492.84 and a fifty-two week high of $654.62. The business has a fifty day simple moving average of $550.03 and a two-hundred day simple moving average of $581.33.

Chemed (NYSE:CHE) last posted its earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). The company had revenue of $595.88 million for the quarter, compared to analyst estimates of $599.20 million. Chemed had a return on equity of 29.21% and a net margin of 12.88%. The firm’s revenue was up 7.6% on a year-over-year basis. During the same period last year, the business earned $4.71 earnings per share. As a group, equities analysts expect that Chemed Co. will post 21.77 earnings per share for the current year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 30th. Shareholders of record on Monday, August 12th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, August 12th. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. This is an increase from Chemed’s previous quarterly dividend of $0.40. Chemed’s dividend payout ratio is currently 10.76%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.